Oncostatin M As a Potential Molecular Target in Systemic SclerosisMaria Feeney, CP Denton, Farhan Syed et al.|UCL Discovery (University College London)|2015Cited by 4
Analysis of a functional polymorphism in the CTGF/CCN2 promoter in Systemic Sclerosis.Carla Fonseca, David Abraham, GE Lindahl et al.|UCL Discovery (University College London)|2005Cited by 0
A novel TGF-beta response element located in the human collagen type I alpha 2 far upstream enhancer is SMAD-independentMarkella Ponticos, Dietmar Abraham, A Holmes et al.|UCL Discovery (University College London)|2006Cited by 0
Macitentan Responsiveness Supports the Validity of a Murine Model of Pulmonary Hypertension in Scleroderma Associated with Altered Tgfbeta/BMPR2 SignallingEC Derrett-Smith, CP Denton, Vincent Sobanski et al.|UCL Discovery (University College London)|2015Cited by 0
Aberrant Bmp Signalling In The Development Of Pulmonary Complications In SclerodermaA Holmes, EC Derrett-Smith, CP Denton|UCL Discovery (University College London)|2014Cited by 0